Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)
Sponsor: Bitop AG
Summary
The aim of this multicentre, actively controlled, randomized, open label, parallel group, prospective, comparator study is to collect data on the clinical effectiveness and tolerability of the medical device ERS09 compared to a well-established comparator spray in the symptomatic treatment of sore throat due to acute pharyngitis and dry cough.
Official title: Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09) Compared to Saline Spray in Patients Suffering From Sore Throat Due to Acute Pharyngitis and Dry Cough
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
INTERVENTIONAL
Enrollment
194
Start Date
2020-01-14
Completion Date
2020-12-04
Last Updated
2026-10-20
Healthy Volunteers
No
Conditions
Interventions
Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)
4 puffs to be administered as needed several times a day for patients aged ≥ 12 years. A maximum of 10 applications per day should not be exceeded.
EMSER® Hals-und Rachenspray (throat spray)
1 to 3 puffs to be administered several times a day
Locations (12)
Dr. Pasch
Aachen, Germany
Dr. Sondermann
Aachen, Germany
Dr. Männer
Arnsberg, Germany
Dr. Kienle-Gogolok
Bad Schönborn, Germany
Dr. Ginko
Bonn, Germany
Dr. Vent
Cologne, Germany
Praxis für Hals-Nasen-Ohren-Heilkunde
Dresden, Germany
Dr. Thieme
Duisburg, Germany
Dr. Horn
Heidelberg, Germany
Dr. Lenzenhuber
Jülich, Germany
Dr. Konzelmann
Röthenbach, Germany
Reiber
Schorndorf, Germany